Daily non-political popular news in brief.

Drug dosages often incorrect for obese patients

As if severely overweight people didn't already have enough health concerns, experts are raising another red flag -- the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.

Read more »

Keywords: drug, dosages, often, incorrect, obese, patients, dosage, patient

« Previous | Next »

Similar news on "Drug dosages often incorrect for obese patients":

1. Hepatitis B patients' understanding of infection and treatment deficient
   05-24-2007 · EurekAlert!
   Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem.
   Similar news · Read more »
   
2. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
   10-10-2007 · EurekAlert!
   Getting the drug dosage correct can be a tricky exercise in trial and error in a disease like multiple sclerosis. Scientists from the Weizmann Institute and the Technion have identified two genes that affect a patient's response to the drug Copaxone, a finding which may help take the some of the guesswork out of treatment.
   Similar news · Read more »
   
3. For treating malaria, less drugs may be best drugs
   11-26-2007 · EurekAlert!
   The current dosage of drugs used in treating malaria may be helping the parasites become resistant to the drugs faster, without improving the long-term outcome in patients. According to evolutionary biologists, studies using mice suggest that the optimal use of the drugs might slow the spread of drug resistance while making the patient just as healthy.
   Similar news · Read more »
   
4. First antisense drug provides benefit to subset of chronic lymphocytic leukemia patients
   02-14-2007 · EurekAlert!
   The first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients - those who are still sensitive to a chemotherapy drug often used to treat this cancer.
   Similar news · Read more »
   
5. Lifetime trauma may speed progression of HIV, early death
   11-01-2007 · EurekAlert!
   Even though effective drug cocktails have improved the outlook for many patients with HIV, disease progression, including the time from AIDS onset to death, varies widely from patient to patient. Now, a study led by the University of North Carolina at Chapel Hill School of Medicine provides new evidence that psychological factors play a role in disease progression.
   Similar news · Read more »
   
6. Catalyst Pharmaceutical Partners Begins Enrollment for its U.S. Phase II Clinical Trial of CPP-109 in Patients With Cocaine Addiction
   01-25-2008 · Brookhaven National Laboratory
   Catalyst Pharmaceutical Partners, Inc. announced today that it has initiated enrollment of patients for its 180-patient, U.S. Phase II clinical trial evaluating the use of CPP-109 in treating patients with cocaine addiction. CPP-109, an orally administered, small molecule drug which inhibits psychostimulant-induced dopamine release, is Catalyst's lead compound, vigabatrin.
   Similar news · Read more »
   
7. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
   12-18-2007 · EurekAlert!
   UT Southwestern Medical Center researchers have found that the existing body mass index criteria for obesity surgery often excludes a group of obese patients at risk of cardiovascular disease.
   Similar news · Read more »
   
8. Medication costs infrequently addressed when newly prescribed, UCLA study finds
   11-08-2006 · EurekAlert!
   A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
   Similar news · Read more »
   
9. Study produces conflicting findings on the use of anti-anemia drug in cancer patients
   04-16-2007 · EurekAlert!
   Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.
   Similar news · Read more »
   
10. Combining medications often best strategy to battle rheumatoid arthritis
    11-19-2007 · EurekAlert!
    For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.
    Similar news · Read more »